Transient Ischemic AttackKTX registryNCT01870531
Korean Transient Ischemic Attack eXpression Registry
An observational study of Transient Ischemic Attack, run by Seoul National University Boramae Hospital at 1 site in South Korea.
Trial summary
This study is to determine the clinical and neuroimaging characteristics of Transient Ischemic Attacks in Korean populations. Read more about this study
- Who is it for?
- Ages 40 years and older
- Conditions the study is for
- Transient Ischemic Attack
- How many people
- 500 participants
- Where
- 1 siteSouth Korea
- Study dates
- Jul 2010to Aug 2013
- How long will I take part?
- 90 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: University Hospitals
Who may be able to join
- Clinical symptoms and signs consistent with transient ischemic attack
- Subject who admitted hospital within 24 hours after symptom onset
- Subjects who underwent MRI (including diffusion-weighted images) and MRA (or CT angiography)
Who cannot join
- Transient neurological symptoms due to
- Migraine aura
- Basilar migraine
- Seizures
- Syncope
- Peripheral vertigo
- Transient global amnesia
Trial locations and contacts
1 site in 1 country.
South Korea1 site
Seoul National University Boramae Hospital
Seoul, Seoul, 156-707
About this study
Official title: Transient Ischemic Attacks in Korean: Hospital-based, Multi-center Prospective Registry
This study is to determine the clinical and neuroimaging characteristics of Transient Ischemic Attacks in Korean populations.
- Conditions
- Transient Ischemic Attack
- Keywords
- Transient Ischemic Attack
- Medical subject headings
- Ischemic Attack, Transient
What is being measured
The primary outcome is the main question the study is designed to answer.
Vascular events including ischemic strokes, myocardial infarctions, cardiovascular deaths
Measured: 90 days
Secondary outcomes (1)
Recurrent transient ischemic attacks
Measured: 90 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jun 2013 (estimated)
- Study startJul 2010
- Primary completionMar 2013
- Study completionAug 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Transient Ischemic AttackStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 500 participants (actual)
- Target duration
- 90 Days
Sponsor and investigators
- Lead sponsor
- Seoul National University Boramae Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yong-Seok Lee, Seoul National University Boramae Hospital
- Investigators
- Yong-Seok Lee, MD, PhD, Principal investigator, Seoul National University Boramae Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01870531
- Sponsor's protocol ID
- 800-20100046
- Acronym
- KTX registry
- Status last verified
- Jun 2015
- First submitted
- 23 May 2013
- Last updated
- 9 Jun 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Jun 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Transient Ischemic Attacks in Korean: Hospital-based, Multi-center Prospective Registry
- ClinicalTrials.gov ID
- NCT01870531
- Acronym / sponsor ID
- KTX registry / 800-20100046
- Conditions
- Transient Ischemic Attack
- Keywords
- Transient Ischemic Attack
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 500 participants (actual)
- Lead sponsor
- Seoul National University Boramae HospitalUniversity, hospital or other
- Study start
- Jul 2010
- Primary completion
- Mar 2013 (actual)
- Study completion
- Aug 2013 (actual)
- First posted
- 6 Jun 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is to determine the clinical and neuroimaging characteristics of Transient Ischemic Attacks in Korean populations.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 90 Days
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- University Hospitals
Key inclusion criteria (3 listed)
- Clinical symptoms and signs consistent with transient ischemic attack
- Subject who admitted hospital within 24 hours after symptom onset
- Subjects who underwent MRI (including diffusion-weighted images) and MRA (or CT angiography)
Key exclusion criteria (7 listed)
- Transient neurological symptoms due to
- Migraine aura
- Basilar migraine
- Seizures
- Syncope
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Vascular events including ischemic strokes, myocardial infarctions, cardiovascular deaths
Time frame: 90 days
1 secondary outcome
Recurrent transient ischemic attacks
Time frame: 90 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jun 2015.
- electronic-case report formLink provided by the sponsor.
Related trials for Transient Ischemic Attack
Not yet recruiting
Cardiac CT Angiography in Acute Stroke Imaging (SCOPE-CT)
Acute Ischemic Stroke and Transient Ischemic Attacks
Not yet recruitingPhase 3
Cilostazol for Prevention of Recurrent Stroke Trial
Stroke Recurrence, Myocardial Infarction
RecruitingObservational study
Natural History of Stroke: Cause and Development
Brain Disease, Ischemic Attack, Transient
Recruiting
Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke
Stroke, Stroke (CVA) or Transient Ischemic Attack
RecruitingObservational study
Estimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)
Ulcerative Colitis, Myocardial Infarction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yong-Seok Lee, MD, PhD principal investigator
Seoul National University Boramae Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Transient Ischemic Attack, run by Seoul National University Boramae Hospital at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Vascular events including ischemic strokes, myocardial infarctions, cardiovascular deaths (time frame: 90 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2015.